Bayer to present new cardiorenal data for Kerendia™ (finerenone) across a broad range of patients with early to late-stage chronic kidney disease and type 2 diabetes

0
16
Bayer to present new cardiorenal data for Kerendia™ (finerenone) across a broad range of patients with early to late-stage chronic kidney disease and type 2 diabetes
Advertisement

////// Science for a better
life





Read More

Advertisement

LEAVE A REPLY

Please enter your comment!
Please enter your name here